Inspire Medical Systems, Inc.

NYSE:INSP

Medical - Devices

Healthcare
$58.11 +1.24%

+$0.51 today

Market cap
$1.68B
Beta
0.73
P/E (TTM)
9.1
EPS (TTM)
$4.57
52W Low $38.91High $147.03

Volume 0.51M

Average 1.13M

INSP EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Inspire Medical Systems, Inc.NYSE: INSP

EBITDA · Q2 FY2026 · quarter ended Jun 2026

EBITDA growth accelerates

Q2 FY2026 EBITDA of $4.08M rose 276.0% year over year, ahead of the -4.7% change in trailing-twelve-month EBITDA. Sequentially, it fell 45.6% from the prior quarter.

Context

  • EBITDA amounted to 8.7% of revenue in FY2025, up 0.6 pp from a year earlier.
  • EBITDA increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 13 analysts of $64.65M (-19.0%) for the fiscal year ending Dec 2026, a slowdown from the +22.7% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$4.08M-45.6% QoQ
Last fiscal yearDec 2025
$79.79M+22.7% YoY
LTMJun 2026
$83.09M-4.7% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+276.0%-51.7%-327.7 pp
1 year+22.7%-19.0%-41.7 pp
3-year CAGR—+5.8%—
5-year CAGR+11.3%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
79.79M USD
Year-over-year change
+22.7%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How INSP compares with its peers on the latest reported figures

  • INSP's LTM Jun 2026 EBITDA of $83.09M is the 6th highest of the 9 companies compared; the peer median is $131.84M.
  • Its year-over-year change of -4.7% is the 5th highest of 9, against a peer median of -1.5%.
  • EBITDA amounts to 9.2% of revenue for INSP, versus a peer median of 15.6%.
INSP Competitors Peer median
EBITDA for INSP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ARDTArdent Health Partners, LLCLTM Mar 2026$505.76M -10.5%-2.2%7.9%
BKDBrookdale Senior Living Inc.LTM Sep 2026$411.59M -8.8%+3.9%14.0%
ITGRInteger Holdings CorporationLTM Jul 2026$313.03M +5.8%+10.2%17.0%
ADUSAddus HomeCare CorporationLTM Jun 2026$167.37M +23.6%+22.7%11.3%
LMATLeMaitre Vascular, Inc.LTM Mar 2026$96.3M +31.7%+35.0%37.6%
INSPInspire Medical Systems, Inc.LTM Jun 2026$83.09M -4.7%—9.2%
AORTArtivion, Inc.LTM Mar 2026$65.05M +84.5%+35.4%14.2%
PRCTPROCEPT BioRobotics CorporationLTM Mar 2026-$92.11M -14.2%—28.6%
RCUSArcus Biosciences, Inc.LTM Jun 2026-$419M -48.6%—358.1%
Peer median (excluding INSP) $131.84M-1.5%+16.4%15.6%

Competitors are the stored peer set for INSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue233.39M407.86M624.8M802.8M911.98M
Cost of Revenue33.28M66.12M96.58M122.99M133.23M
Gross Profit200.12M341.74M528.22M679.82M778.76M
Gross Margin85.7%83.8%84.5%84.7%85.4%
Research & Development37.35M68.65M116.54M114.13M103.17M
Selling, General & Admin202.62M320.69M451.96M529.61M624.64M
Operating Expenses239.97M389.33M568.49M643.74M727.8M
Depreciation & Amortization1.22M1.86M2.85M6.55M13.96M
EBITDA(38.62M)(40.73M)(17.06M)65.03M79.79M
EBITDA Margin-16.5%-10.0%-2.7%8.1%8.7%
Operating Income(39.85M)(47.59M)(40.27M)36.08M50.95M
Operating Margin-17.1%-11.7%-6.4%4.5%5.6%
Interest Income125K5.05M20.56M23.25M17.54M
Interest Expense2.13M1.68M022K137K
Other Income / Expenses(2.12M)3.32M20.37M22.37M14.74M
Income Before Tax(41.97M)(44.27M)(19.91M)58.45M65.7M
Pre-Tax Margin-18.0%-10.9%-3.2%7.3%7.2%
Income Tax Expense72K613K1.25M4.94M(79.73M)
Net Income(42.04M)(44.88M)(21.15M)53.51M145.42M
Net Margin-18.0%-11.0%-3.4%6.7%15.9%
EPS (Basic)(1.54)(1.60)(0.72)1.804.95
EPS (Diluted)(1.54)(1.60)(0.72)1.754.89
Weighted Avg Shares27.26M28.07M29.3M29.76M29.37M
Weighted Avg Shares (Diluted)27.26M28.07M29.3M30.54M29.76M

Inspire Medical Systems, Inc.

NYSE:INSP

Intrinsic Alpha fair value

Locked

Current Price

$58.11

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.